Purple Biotech Files Mixed-Securities Shelf Registration

MT Newswires Live

Aug 29

Purple Biotech (PPBT) said in a regulatory filing Friday it plans to offer "on a reasonable best efforts" basis up to 2,702,702 American Depositary Shares representing 540,540,400 common shares at a currently assumed estimated combined price of $2.22 per ADS, and accompanying and other prefunded warrants, 'from time-to-time.'

Each ADS represents 200 Purple Biotech common shares, the company said.

The company has hired H.C. Wainwright & Co as "placement agent" in connection with the offering, which will expire Oct. 3, unless the company decides to terminate it at any time earlier, according to the F-1 filing.

If and when sold, the company said, it plans to use the proceeds from the offering to develop its oncology therapeutic candidates, and for general working capital and corporate purposes.

Shares of Purple Biotech were down 8% in recent Friday trading.

Price: 2.19, Change: -0.08, Percent Change: -3.52

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2563600024"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2563600024\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2563600024?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-29 22:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2563600024","market":"us","top_or_hot":-1,"title":"Purple Biotech Files Mixed-Securities Shelf Registration","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/PPBT\">Purple Biotech</a> (PPBT) said in a regulatory filing Friday it plans to offer \"on a reasonable best efforts\" basis up to 2,702,702 American Depositary Shares representing 540,540,400 common shares at a currently assumed estimated combined price of $2.22 per ADS, and accompanying and other prefunded warrants, 'from time-to-time.'</p><p>Each ADS represents 200 Purple Biotech common shares, the company said.</p><p>The company has hired H.C. Wainwright &amp; Co as \"placement agent\" in connection with the offering, which will expire Oct. 3, unless the company decides to terminate it at any time earlier, according to the F-1 filing.</p><p>If and when sold, the company said, it plans to use the proceeds from the offering to develop its oncology therapeutic candidates, and for general working capital and corporate purposes.</p><p>Shares of Purple Biotech were down 8% in recent Friday trading.</p><p>Price: 2.19, Change: -0.08, Percent Change: -3.52</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Purple Biotech Files Mixed-Securities Shelf Registration</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPurple Biotech Files Mixed-Securities Shelf Registration\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-08-29 22:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/PPBT\">Purple Biotech</a> (PPBT) said in a regulatory filing Friday it plans to offer \"on a reasonable best efforts\" basis up to 2,702,702 American Depositary Shares representing 540,540,400 common shares at a currently assumed estimated combined price of $2.22 per ADS, and accompanying and other prefunded warrants, 'from time-to-time.'</p><p>Each ADS represents 200 Purple Biotech common shares, the company said.</p><p>The company has hired H.C. Wainwright &amp; Co as \"placement agent\" in connection with the offering, which will expire Oct. 3, unless the company decides to terminate it at any time earlier, according to the F-1 filing.</p><p>If and when sold, the company said, it plans to use the proceeds from the offering to develop its oncology therapeutic candidates, and for general working capital and corporate purposes.</p><p>Shares of Purple Biotech were down 8% in recent Friday trading.</p><p>Price: 2.19, Change: -0.08, Percent Change: -3.52</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PPBT","symbol_name":"Purple Biotech Ltd.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2563600024","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2563600024","pubTimestamp":1756477316,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Purple Biotech  said in a regulatory filing Friday it plans to offer \"on a reasonable best efforts\" basis up to 2,702,702 American Depositary Shares representing 540,540,400 common shares at a currently assumed estimated combined price of $2.22 per ADS, and accompanying and other prefunded warrants, 'from time-to-time.'Each ADS represents 200 Purple Biotech common shares, the company said.The company has hired H.C. Wainwright & Co as \"placement agent\" in connection with the offering, which will expire Oct. 3, unless the company decides to terminate it at any time earlier, according to the F-1 filing.If and when sold, the company said, it plans to use the proceeds from the offering to develop its oncology therapeutic candidates, and for general working capital and corporate purposes.Shares of Purple Biotech were down 8% in recent Friday trading.Price: 2.19, Change: -0.08, Percent Change: -3.52","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PPBT":"Purple Biotech Ltd.","BK4007":"制药"},"translate_title":"Purple Biotech提交混合证券货架登记","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PPBT":0.9},"content_text":"Purple Biotech (PPBT) said in a regulatory filing Friday it plans to offer \"on a reasonable best efforts\" basis up to 2,702,702 American Depositary Shares representing 540,540,400 common shares at a currently assumed estimated combined price of $2.22 per ADS, and accompanying and other prefunded warrants, 'from time-to-time.'Each ADS represents 200 Purple Biotech common shares, the company said.The company has hired H.C. Wainwright & Co as \"placement agent\" in connection with the offering, which will expire Oct. 3, unless the company decides to terminate it at any time earlier, according to the F-1 filing.If and when sold, the company said, it plans to use the proceeds from the offering to develop its oncology therapeutic candidates, and for general working capital and corporate purposes.Shares of Purple Biotech were down 8% in recent Friday trading.Price: 2.19, Change: -0.08, Percent Change: -3.52","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}